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Emerging and neglected infections have proven to be highly
lethal with mortality rates ranging from 10 to 80%. However,
with a low incidence of disease, less public attention and
support have been directed at these infections. Much more
research is devoted to infections with a large public health
impact, neglecting these potential diseases. Nonetheless,
there are numerous infectious diseases waiting for the evolu-
tionary or nefarious alteration that will allow them to spread
readily among the human population.
At the time of conception of this special issue, the Zika
virus epidemic in the Western Hemisphere has been raging
for over a year continually spreading northward from Brazil
and Colombia into Latin America, Mexico, and finally the
United States of America. Zika has grabbed the public’s
attention and forced it to pay attention to this emerging
disease with over 125,000 cases in 40 countries. However,
the Zika virus was originally identified in 1947 with the first
human cases documented in 1952 in Uganda. Subsequently,
only sporadic human infections were reported until the
localized Yap Island outbreak in 2007. Zika virus then receded
into obscurity until the recent explosion of Zika-associated
microcephaly cases. However, this is just the latest in a string
of emerging or neglected diseases to bask in the stage lights
of the public health community. Similarly, the Ebola virus
outbreak of 2014–2016 is just the latest in a long series of local,
regional, and global outbreaks spanning all the way back to
1976. We cannot ignore pathogens with low incidences of
disease as these are just the pathogens that could cause the
next epidemic.
Therefore, we have assembled a series of manuscripts
addressing the topic of this special issue. Manuscripts pub-
lished in this special issue address topics in bacterial, viral,
and parasitic infections ranging from novel treatments and
diagnostics to epidemiology and clinical studies.
K. C. Kosinski et al. from the United States of Amer-
ica present a comparative epidemiological study of several
assessments indicative of a clinical diagnostic of Schistosoma
haematobium in Ghanaian children and found agreement
between a dipstick self-test and clinical diagnosis of the
presence of eggs in the urine.
A. Vina-Rodriguez et al. from Germany describe a novel
TaqMan-based quantitative real-time PCR assay for the diag-
nosis and differentiation of Venezuelan equine encephalitis
virus. This high throughput assay could greatly facilitate
detection and surveillance of VEEV.
S. Petti et al. from Italy present an epidemiological study
of healthcare works tending Ebola virus victims during the
last outbreak. Despite having proper training and protec-
tive equipment, some of these healthcare workers became
infected without direct exposure to blood/bodily fluids.
Based on their retrospective study, the authors hypothesize
that these healthcare workers became infected while working
with asymptomatic patients, although they cannot discount
unremembered exposure to blood/bodily fluids.
E. Franceschini et al. from Italy have characterized the
clinical and microbiological features of an outbreak of vis-
ceral leishmaniasis in a province inNorthern Italy concluding
that despite being a nonendemic area for Leishmania infan-
tum, rare diseases must be considered for symptoms with
unknown etiology.
D. A. Yones et al. from Egypt compared the anti-
helminthic activity of edible and ornamental pomegranate
extracts with the goal of identifying novel and effective
new candidates for the development of drugs potent against
Schistosoma mansoni.
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P. Lou et al. from China present a novel algorithm for
predicting and modelling Brucellosis epidemics that can be
used to developing possible interventions to prevent local
outbreaks from developing into epidemics.
M. P. Herna´ndez-Rivera et al. from Mexico present the
results of their association study betweenNRAMP1 polymor-
phisms and cutaneous leishmaniasis. This study could lead
to greater accuracy in treatment of a diverse populace with
cutaneous leishmaniasis.
C. L. Hoyos et al. from Argentina present an epidemio-
logical study of the prevalence, magnitude, and risk factors
of Leishmania/Trypanosoma cruzi coinfection in an endemic
area of Argentina.
P. Gundelly et al. from the United States of America
present the clinical findings of a group of patients in the
USA infected with Rhodococcus equi discussing changes in
the prevalence and magnitude of infections.
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